Company intelligence / Profile preview

O2TODAY

Salt Lake City, Utah, United States

Ownership: Private
Development stage: Other

Overview

O2TODAY develops and commercializes proprietary face mask technology (including surgical, respirator-style, and reusable masks with replacement filters) to reduce exposure to respiratory droplets, pathogens, allergens, dust, wildfire haze, and PM2.5 air pollution; in 2020 it entered a joint development agreement with SINTX Technologies to create antimicrobial masks incorporating silicon nitride with demonstrated inactivation of SARS-CoV‑2 in lab studies.

Therapeutic areas: PulmonologyInfectious Diseases
Modalities: DeviceNon-pharmacological therapy
Industry: Consumable Medical Devices

Partnerships

SINTX Technologies (joint development and commercialization agreement to develop and distribute antimicrobial face masks and filters containing silicon nitride)[1][5]

Beyond the preview

Go deeper on O2TODAY.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on O2TODAY.

Explore the full profile